Wolverine Trading’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-176,200
| Closed | -$1.23M | – | 5317 |
|
|
2025
Q1 | $1.23M | Buy |
176,200
+3,700
| +2% | +$30.6K | ﹤0.01% | 2051 |
|
|
2024
Q4 | $1.37M | Sell |
172,500
-45,300
| -21% | -$437K | ﹤0.01% | 2340 |
|
|
2024
Q3 | $2.9M | Buy |
217,800
+58,400
| +37% | +$754K | ﹤0.01% | 1426 |
|
|
2024
Q2 | $2.02M | Buy |
159,400
+82,900
| +108% | +$834K | ﹤0.01% | 1604 |
|
|
2024
Q1 | $366K | Buy |
+76,500
| New | +$355K | ﹤0.01% | 3151 |
|
|
2023
Q4 | – | Sell |
-213,200
| Closed | -$1.54M | – | 4978 |
|
|
2023
Q3 | $1.54M | Buy |
+213,200
| New | +$1.7M | ﹤0.01% | 1780 |
|
|
2023
Q2 | – | Sell |
-135,000
| Closed | -$890K | – | 4710 |
|
|
2023
Q1 | $890K | Sell |
135,000
-125,100
| -48% | -$1.15M | ﹤0.01% | 1994 |
|
|
2022
Q4 | $2.67M | Buy |
+260,100
| New | +$4.59M | ﹤0.01% | 1221 |
|
|
2022
Q3 | – | Sell |
-130,900
| Closed | -$6.79M | – | 5100 |
|
|
2022
Q2 | $6.79M | Sell |
130,900
-4,000
| -3% | -$207K | 0.01% | 678 |
|
|
2022
Q1 | $10.1M | Sell |
134,900
-54,200
| -29% | -$4.83M | 0.01% | 693 |
|
|
2021
Q4 | $29.3M | Sell |
189,100
-34,900
| -16% | -$6M | 0.03% | 361 |
|
|
2021
Q3 | $45.6M | Sell |
224,000
-7,200
| -3% | -$1.59M | 0.05% | 251 |
|
|
2021
Q2 | $48.3M | Buy |
231,200
+38,900
| +20% | +$7.13M | 0.08% | 193 |
|
|
2021
Q1 | $33.3M | Buy |
192,300
+24,000
| +14% | +$4.78M | 0.05% | 258 |
|
|
2020
Q4 | $20M | Buy |
168,300
+8,800
| +6% | +$935K | 0.03% | 398 |
|
|
2020
Q3 | $17.2M | Buy |
159,500
+66,100
| +71% | +$8.05M | 0.04% | 345 |
|
|
2020
Q2 | $7.81M | Sell |
93,400
-18,900
| -17% | -$723K | 0.02% | 584 |
|
|
2020
Q1 | $1.61M | Buy |
+112,300
| New | +$950K | ﹤0.01% | 1524 |
|
|
2019
Q1 | – | Sell |
-6,920
| Closed | -$255K | – | 5052 |
|
|
2018
Q4 | $255K | Buy |
6,920
+2,600
| +60% | +$101K | ﹤0.01% | 3389 |
|
|
2018
Q3 | $162K | Buy |
4,320
+260
| +6% | +$7.32K | ﹤0.01% | 4358 |
|
|
2018
Q2 | $171K | Hold |
4,060
| – | – | ﹤0.01% | 4480 |
|
|
2018
Q1 | $171K | Buy |
4,060
+1,840
| +83% | +$73.9K | ﹤0.01% | 4480 |
|
|
2017
Q4 | $55K | Buy |
2,220
+400
| +22% | +$9.76K | ﹤0.01% | 4595 |
|
|
2017
Q3 | $41K | Sell |
1,820
-510
| -22% | -$11.4K | ﹤0.01% | 4258 |
|
|
2017
Q2 | $54K | Buy |
2,330
+565
| +32% | +$11.1K | ﹤0.01% | 4040 |
|
|
2017
Q1 | $44K | Sell |
1,765
-540
| -23% | -$14.8K | ﹤0.01% | 4023 |
|
|
2016
Q4 | $58K | Sell |
2,305
-3,130
| -58% | -$91.3K | ﹤0.01% | 4185 |
|
|
2016
Q3 | $224K | Buy |
5,435
+565
| +12% | +$72.9K | ﹤0.01% | 3672 |
|
|
2016
Q2 | $698K | Buy |
+4,870
| New | +$558K | ﹤0.01% | 1904 |
|
Other funds holding NVAX
SCM
S
Wolverine Trading's NVAX Position: Q2 2025 in Review
Wolverine Trading sold out of Novavax (NVAX) in Q2 2025, closing a stake of 24,208 shares — an estimated $169K sold.
Wolverine Trading first reported a position in NVAX in Q2 2016 and held it in 24 quarters. The position peaked at $8.63M in Q2 2021. 250 funds tracked by Wall St. Rank hold NVAX as of Q2 2025.
- Wolverine Trading reported no remaining Novavax position as of Q2 2025 after selling out during the quarter.
- Wolverine Trading sold 24,208 Novavax shares in Q2 2025, an estimated $169K.
- Wolverine Trading first reported a position in Novavax in Q2 2016 and held it in 24 quarters.
- Wolverine Trading's Novavax position peaked at $8.63M in Q2 2021.
- 250 funds tracked by Wall St. Rank held Novavax as of Q2 2025.
Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.